Optical electrophysiology for probing function and pharmacology of voltage-gated ion channels

Voltage-gated ion channels mediate electrical dynamics in excitable tissues and are an important class of drug targets. Channels can gate in sub-millisecond timescales, show complex manifolds of conformational states, and often show state-dependent pharmacology. Mechanistic studies of ion channels typically involve sophisticated voltage-clamp protocols applied through manual or automated electrophysiology. Here, we develop all-optical electrophysiology techniques to study activity-dependent modulation of ion channels, in a format compatible with high-throughput screening. Using optical electrophysiology, we recapitulate many voltage-clamp protocols and apply to Nav1.7, a channel implicated in pain. Optical measurements reveal that a sustained depolarization strongly potentiates the inhibitory effect of PF-04856264, a Nav1.7-specific blocker. In a pilot screen, we stratify a library of 320 FDA-approved compounds by binding mechanism and kinetics, and find close concordance with patch clamp measurements. Optical electrophysiology provides a favorable tradeoff between throughput and information content for studies of NaV channels, and possibly other voltage-gated channels. DOI: http://dx.doi.org/10.7554/eLife.15202.001

[1]  J. Nerbonne,et al.  Distinct Transient Outward Potassium Current (Ito) Phenotypes and Distribution of Fast-inactivating Potassium Channel Alpha Subunits in Ferret Left Ventricular Myocytes , 1999, The Journal of general physiology.

[2]  G. Wang,et al.  State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain , 2004, Pain.

[3]  R. Aldrich,et al.  BK potassium channel modulation by leucine-rich repeat-containing proteins , 2012, Proceedings of the National Academy of Sciences.

[4]  Jun Li,et al.  Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist , 2015, Science.

[5]  Michael Z. Lin,et al.  High-fidelity optical reporting of neuronal electrical activity with an ultrafast fluorescent voltage sensor , 2014, Nature Neuroscience.

[6]  Leslie M. Loew,et al.  Probing the function of neuronal populations: Combining micromirror-based optogenetic photostimulation with voltage-sensitive dye imaging , 2013, Neuroscience Research.

[7]  D. T. Yue,et al.  Optical mapping of optogenetically shaped cardiac action potentials , 2014, Scientific Reports.

[8]  D. Kleinfeld,et al.  Long-term optical recording of patterns of electrical activity in ensembles of cultured Aplysia neurons. , 1991, Journal of neurophysiology.

[9]  D. Tank,et al.  Simultaneous cellular-resolution optical perturbation and imaging of place cell firing fields , 2014, Nature Neuroscience.

[10]  G. Salama,et al.  Properties of New, Long-Wavelength, Voltage-sensitive Dyes in the Heart , 2005, The Journal of Membrane Biology.

[11]  S. van de Linde,et al.  Light-induced cell damage in live-cell super-resolution microscopy , 2015, Scientific Reports.

[12]  Evan W. Miller,et al.  A Photostable Silicon Rhodamine Platform for Optical Voltage Sensing. , 2015, Journal of the American Chemical Society.

[13]  A. Scholz,et al.  Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels. , 2002, British journal of anaesthesia.

[14]  D. Maclaurin,et al.  Optical recording of action potentials in mammalian neurons using a microbial rhodopsin , 2011, Nature Methods.

[15]  Michael Häusser,et al.  Simultaneous all-optical manipulation and recording of neural circuit activity with cellular resolution in vivo , 2014, Nature Methods.

[16]  Min Li,et al.  High throughput screening technologies for ion channels , 2015, Acta Pharmacologica Sinica.

[17]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[18]  F. Conti,et al.  Use dependence of tetrodotoxin block of sodium channels: a revival of the trapped-ion mechanism. , 1996, Biophysical journal.

[19]  C. Hempel,et al.  A System for Performing High Throughput Assays of Synaptic Function , 2011, PloS one.

[20]  M. Main,et al.  Use of Escin as a Perforating Agent on the IonWorks Quattro Automated Electrophysiology Platform , 2013, Journal of biomolecular screening.

[21]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[22]  L B Cohen,et al.  Optical measurement of membrane potential. , 1978, Reviews of physiology, biochemistry and pharmacology.

[23]  R. Peri,et al.  High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology , 2008, Nature Reviews Drug Discovery.

[24]  Gareth J Waldron,et al.  Reducing safety-related drug attrition: the use of in vitro pharmacological profiling , 2012, Nature Reviews Drug Discovery.

[25]  Beiyan Zou,et al.  Reporting Sodium Channel Activity Using Calcium Flux: Pharmacological Promiscuity of Cardiac Nav1.5 , 2015, Molecular Pharmacology.

[26]  Marc Gewillig,et al.  A Novel mutation L619F in the cardiac Na+ channel SCN5A associated with long‐QT syndrome (LQT3): a role for the I‐II linker in inactivation gating , 2003, Human mutation.

[27]  Christopher A. Werley,et al.  Screening Fluorescent Voltage Indicators with Spontaneously Spiking HEK Cells , 2013, PloS one.

[28]  Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation* , 2009, Journal of Biological Chemistry.

[29]  Peter Hegemann,et al.  Rectification of the channelrhodopsin early conductance. , 2011, Biophysical journal.

[30]  Samouil L. Farhi,et al.  All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins , 2014, Nature Methods.

[31]  Minna Männikkö,et al.  Pain perception is altered by a nucleotide polymorphism in SCN9A , 2010, Proceedings of the National Academy of Sciences.

[32]  Viviana Agus,et al.  Bringing the light to high throughput screening: use of optogenetic tools for the development of recombinant cellular assays , 2015, Photonics West - Biomedical Optics.

[33]  Flavia Mancini,et al.  Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7 , 2015, Nature Communications.

[34]  I. Raman,et al.  Interactions among DIV voltage-sensor movement, fast inactivation, and resurgent Na current induced by the NaVβ4 open-channel blocking peptide , 2013, The Journal of general physiology.

[35]  E. Perozo,et al.  Voltage-dependent gating at the KcsA selectivity filter , 2006, Nature Structural &Molecular Biology.

[36]  Leslie M. Loew,et al.  Intracellular long-wavelength voltage-sensitive dyes for studying the dynamics of action potentials in axons and thin dendrites , 2007, Journal of Neuroscience Methods.

[37]  S. Dib-Hajj,et al.  The NaV1.7 sodium channel: from molecule to man , 2012, Nature Reviews Neuroscience.

[38]  John N. Wood,et al.  SCN9A Mutations in Paroxysmal Extreme Pain Disorder: Allelic Variants Underlie Distinct Channel Defects and Phenotypes , 2006, Neuron.

[39]  E. Neher.  Correction for liquid junction potentials in patch clamp experiments. , 1992, Methods in enzymology.

[40]  V. Bondarenko,et al.  Heteropoda toxin 2 is a gating modifier toxin specific for voltage-gated K+ channels of the Kv4 family. , 2005, Toxicon : official journal of the International Society on Toxinology.

[41]  S. Heinemann,et al.  Heterologous expression of NaV1.9 chimeras in various cell systems , 2015, Pflügers Archiv - European Journal of Physiology.

[42]  W. N. Ross,et al.  Changes in axon fluorescence during activity: Molecular probes of membrane potential , 1974, The Journal of Membrane Biology.

[43]  Robert D. Kirkton,et al.  Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies. , 2011, Nature communications.

[44]  B. Ding,et al.  Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.

[45]  A. L. Goldin,et al.  A voltage-dependent gating transition induces use-dependent block by tetrodotoxin o rat IIA sodium channels expressed in xenopus oocytes , 1991, Neuron.

[46]  B. Ho,et al.  Slow and incomplete inactivations of voltage-gated channels dominate encoding in synthetic neurons. , 1993, Biophysical journal.

[47]  M. D. de Groot,et al.  Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels , 2013, Proceedings of the National Academy of Sciences.

[48]  Wei Li,et al.  Intraflagellar transport protein IFT20 is essential for male fertility and spermiogenesis in mice , 2016, Molecular biology of the cell.

[49]  W. Wadman,et al.  Properties of human brain sodium channel α‐subunits expressed in HEK293 cells and their modulation by carbamazepine, phenytoin and lamotrigine , 2014, British journal of pharmacology.

[50]  Y. Imaizumi,et al.  Development of Recombinant Cell Line Co-expressing Mutated Nav1.5, Kir2.1, and hERG for the Safety Assay of Drug Candidates , 2012, Journal of biomolecular screening.

[51]  Jianhua He,et al.  Crystal structure of an orthologue of the NaChBac voltage-gated sodium channel , 2012, Nature.

[52]  D. G. Gibson,et al.  Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.

[53]  K. Swartz,et al.  Deconstructing voltage sensor function and pharmacology in sodium channels , 2008, Nature.

[54]  M. Häusser,et al.  All-Optical Interrogation of Neural Circuits , 2015, The Journal of Neuroscience.

[55]  William A Catterall,et al.  Voltage‐gated sodium channels at 60: structure, function and pathophysiology , 2012, The Journal of physiology.

[56]  P. Hegemann,et al.  Fast, repetitive light-activation of CaV3.2 using Channelrhodopsin 2 , 2010, Channels.